In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...
Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...
Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...
This is a guest post by Nathan Paxton. As social scientists, at least as regards what we can empirically assess, we tend to make statements of probability rather than fact. So rather than say that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results